141 related articles for article (PubMed ID: 22042419)
1. [MicroRNA expression pattern in intraductal papillary mucinous neoplasm].
Park YG; Lee KH; Lee JK; Lee KT; Choi DW; Choi SH; Heo JS; Jang KT; Lee EM; Kim JO; Min SY; Kim EJ
Korean J Gastroenterol; 2011 Oct; 58(4):190-200. PubMed ID: 22042419
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
3. EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.
Kuroki H; Hayashi H; Okabe H; Hashimoto D; Takamori H; Nakahara O; Nakagawa S; Fukushima Y; Chikamoto A; Beppu T; Hirota M; Iyama K; Baba H
PLoS One; 2014; 9(8):e100904. PubMed ID: 25084021
[TBL] [Abstract][Full Text] [Related]
4. hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms.
Chang X; Yu C; Li J; Yu S; Chen J
Int J Med Sci; 2017; 14(5):412-418. PubMed ID: 28539816
[No Abstract] [Full Text] [Related]
5. MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
Kuratomi N; Takano S; Fukasawa M; Maekawa S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Takada H; Nakakuki N; Kato R; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Inoue T; Kondo T; Ichikawa D; Enomoto N
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809988
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.
Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm.
Tanaka T; Kuroki T; Adachi T; Ono S; Hirabaru M; Soyama A; Kitasato A; Takatsuki M; Hayashi T; Eguchi S
Pancreas; 2013 Apr; 42(3):488-93. PubMed ID: 23146920
[TBL] [Abstract][Full Text] [Related]
9. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
[TBL] [Abstract][Full Text] [Related]
10. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
11. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
[TBL] [Abstract][Full Text] [Related]
12. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
[TBL] [Abstract][Full Text] [Related]
13. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin.
Hamada S; Satoh K; Miura S; Hirota M; Kanno A; Masamune A; Kikuta K; Kume K; Unno J; Egawa S; Motoi F; Unno M; Shimosegawa T
J Cell Physiol; 2013 Jun; 228(6):1255-63. PubMed ID: 23139153
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
Habbe N; Koorstra JB; Mendell JT; Offerhaus GJ; Ryu JK; Feldmann G; Mullendore ME; Goggins MG; Hong SM; Maitra A
Cancer Biol Ther; 2009 Feb; 8(4):340-6. PubMed ID: 19106647
[TBL] [Abstract][Full Text] [Related]
15. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
[TBL] [Abstract][Full Text] [Related]
16. The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.
Caponi S; Funel N; Frampton AE; Mosca F; Santarpia L; Van der Velde AG; Jiao LR; De Lio N; Falcone A; Kazemier G; Meijer GA; Verheul HM; Vasile E; Peters GJ; Boggi U; Giovannetti E
Ann Oncol; 2013 Mar; 24(3):734-41. PubMed ID: 23139258
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
[TBL] [Abstract][Full Text] [Related]
18. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
19. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma.
Tanaka M
Pancreas; 2018; 47(5):544-550. PubMed ID: 29702531
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]